Saudi Arabia Interventional Cardiology Devices Market Size & Outlook

The interventional cardiology devices market in Saudi Arabia is expected to reach a projected revenue of US$ 59.7 million by 2030. A compound annual growth rate of 4.1% is expected of Saudi Arabia interventional cardiology devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$45.1
Forecast, 2030 (US$M)
$59.7
CAGR, 2024 - 2030
4.1%
Report Coverage
Saudi Arabia

Saudi Arabia interventional cardiology devices market, 2018-2030 (US$M)

Saudi

Related Markets

Saudi Arabia interventional cardiology devices market highlights

  • The Saudi Arabia interventional cardiology devices market generated a revenue of USD 45.1 million in 2023 and is expected to reach USD 59.7 million by 2030.
  • The Saudi Arabia market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
  • In terms of segment, coronary stents was the largest revenue generating product in 2023.
  • Accessory Devices is the most lucrative product segment registering the fastest growth during the forecast period.


Interventional cardiology devices market data book summary

Market revenue in 2023USD 45.1 million
Market revenue in 2030USD 59.7 million
Growth rate4.1% (CAGR from 2023 to 2030)
Largest segmentCoronary stents
Fastest growing segmentAccessory Devices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIntravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.5% of the global interventional cardiology devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa interventional cardiology devices market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 105.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Cardiology Devices Market Scope

Interventional cardiology devices market segmentation & scope
Intravascular Imaging Catheters and Pressure Guidewires
DES
BMS
BRS
Normal
Specialty
DCB
PTCA Guidewires
PTCA Guiding Catheters
Introducer Sheaths

Interventional Cardiology Devices Market Companies

Name Profile # Employees HQ Website

Saudi Arabia interventional cardiology devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.


Coronary stents was the largest segment with a revenue share of 49.89% in 2023. Horizon Databook has segmented the Saudi Arabia interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.


Increasing healthcare expenditure with growing number of hospitals and rising target population across the country is expected to contribute to market growth. For instance, in September 2023, an article by Cardiac Interventions highlighted a review of TARGET IV trial for Firehawk rapamycin-eluting coronary stent made from cobalt chromium.

The first three trials have shown promising results among patient populations across 40 countries, including Saudi Arabia. According to a recent article released by Saudi Food and Drug Authority (SFDA), the Paclitaxel eluting stent and Paclitaxel coated balloon products were examined in a postmarket evaluation in Saudi Arabia by international regulatory offices and specialized societies.

Moreover, the SFDA took the initiative to evaluate the safety of Paclitaxel eluting stent and Paclitaxel coated balloon with reference to recent accumulated clinical data, which revealed that they carry the risk of long-term mortality. However, more studies are required when it is compared to noncoated devices.

Reasons to subscribe to Saudi Arabia interventional cardiology devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia interventional cardiology devices market databook

  • Our clientele includes a mix of interventional cardiology devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia interventional cardiology devices market size, by product, 2018-2030 (US$M)

Saudi Arabia Interventional Cardiology Devices Market Outlook Share, 2023 & 2030 (US$M)

Saudi Arabia interventional cardiology devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more